Orgenesis Inc.
ORGS
$2.27
-$0.0525-2.26%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 215.45% | 117.70% | -0.70% | -98.79% | -98.62% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 215.45% | 117.70% | -0.70% | -98.79% | -98.62% |
| Cost of Revenue | 320.86% | -83.35% | -81.93% | -93.17% | -85.86% |
| Gross Profit | -720.69% | 90.64% | 86.40% | -99.97% | -100.41% |
| SG&A Expenses | 113.98% | -88.69% | -55.23% | -68.60% | -59.89% |
| Depreciation & Amortization | 28.10% | 8.65% | -26.09% | -32.00% | -32.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 239.79% | -82.87% | -54.04% | -58.55% | -70.67% |
| Operating Income | -240.98% | 83.77% | 54.43% | -1,321.66% | -31,828.57% |
| Income Before Tax | -177.21% | 69.90% | 57.03% | -514.91% | -140.85% |
| Income Tax Expenses | -91.88% | -94.51% | -87.60% | -181.98% | 1,476.00% |
| Earnings from Continuing Operations | -148.75% | 69.97% | 57.20% | -420.68% | -164.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -91.82% | -93.86% | 100.00% | -- |
| Net Income | -144.83% | 65.14% | 49.85% | -61.65% | -174.71% |
| EBIT | -240.98% | 83.77% | 54.43% | -1,321.66% | -31,828.57% |
| EBITDA | -246.53% | 86.26% | 55.05% | -638.25% | -524.95% |
| EPS Basic | -55.90% | 70.04% | 66.31% | -37.73% | -132.43% |
| Normalized Basic EPS | -57.27% | 62.84% | 46.50% | 36.16% | -116.82% |
| EPS Diluted | -55.90% | 70.04% | 66.31% | -35.56% | -132.43% |
| Normalized Diluted EPS | -57.27% | 62.84% | 46.50% | 36.16% | -116.82% |
| Average Basic Shares Outstanding | 57.05% | 35.86% | 25.25% | 17.37% | 18.18% |
| Average Diluted Shares Outstanding | 57.05% | 35.86% | 25.25% | 17.37% | 18.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |